A clearer reading

Longitudinal Outpatient Treatment for Cannabis Use Disorder

Registry metadata, preparation and research links; registration is not proof of benefit.

Content reviewed 2026-10-25 · Local preview

Registration describes a study. It does not establish benefit, retail product efficacy, vendor quality or current recruitment availability.

NCT06107062 · CBD, THC

Registry status
Recruiting — sponsor-reported
Phase
Phase 2
Registry results
No results tables posted in registry
Study preparation
Full-spectrum CBD capsules, broad-spectrum CBD capsules and placebo are separate study arms.
Population
Adults with cannabis use disorder.
Registered enrollment
165 (estimated)
Lead sponsor
University of Colorado, Boulder
First posted
2023-10-30
Registry last update posted
2026-06-12
Sponsor status verified
2025-06
Our source check
2026-10-25
Interpretation limit

Linked research is background, not a result of this ongoing study. Registry descriptions of spectrum or THC are protocol claims, not tested retail batches.

Read the related research in context.

Background topic only; this paper is not a result of this registered study.

Related primary paper

Registration versus results · All curated registry examples

Suggest a source correction

Copy a note and share it with the person who sent this preview. This page does not send or store your note.

Nothing has been sent.